Evidence map›Paper›PMID 39911365›Full record

ArticleThe Pan African medical journal2024

Sero-prevalence and risk factors for maternal and umbilical cord hepatitis B surface antigenaemia at delivery in a South-West Nigerian State.

Babatunde Olaniyi Roiji, Adepeju Dorca Roiji, Olumide Ebeezer Adewara, Musah Yusuf, Olajide Alfred Durojaye, Omotayo Oladele Adeniyi, Micheal Olumide Gbala, Babatola Bakare, Babatunde Ajayi Olofinbiyi

Abstract read
In one paragraph

Article in The Pan African medical journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Babatunde Olaniyi RoijiDepartment of Obstetrics and Gynaecology, State Specialist Hospital, Ikole-Ekiti, Ekiti State, Nigeria.
Adepeju Dorca RoijiDepartment of Pharmacology, Federal Teaching Hospital, Ido-Ekiti, Ekiti State, Nigeria.
Olumide Ebeezer AdewaraDepartment of Obstetrics and Gynaecology, Federal Teaching Hospital, Ido-Ekiti, Ekiti State, Nigeria.
Musah YusufDepartment of Internal Medicine, Federal Teaching Hospital, Ido-Ekiti, Ekiti State, Nigeria.
Olajide Alfred DurojayeLegal Medical Clinic, Legal, Alberta, Canada.
Omotayo Oladele AdeniyiBayly Family Practice and Walk in Clinic, Bayly Street, Toronto, Canada.
Micheal Olumide GbalaDepartment of Obstetrics and Gynaecology, University of Medical Sciences Teaching Hospital, Ondo, Ondo State, Nigeria.
Babatola BakareDepartment of Obstetrics and Gynaecology, University of Medical Sciences Teaching Hospital, Ondo, Ondo State, Nigeria.
Babatunde Ajayi OlofinbiyiDepartment of Obstetrics and Gynaecology, College of Medicine, Ekiti State University, Ado-Ekiti, Ekiti State, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: hepatitis B is a global public health issue affecting about 2 billion people, with 350 million chronic carriers. There is growing pressure to test pregnant women for hepatitis B in Nigeria, as studies show high rates of the virus in both mothers and children. Objectives: this cross-sectional study aimed at determining the sero-prevalence of hepatitis B surface antigen among pregnant women and their newborns and identifying risk factors associated with hepatitis B surface antigen positivity among pregnant women receiving care in tertiary hospitals in Ekiti State, Southwest Nigeria. Methods: two hundred women were recruited into the study from Federal Teaching Hospital, Ido-Ekiti, and Ekiti State University Teaching Hospital, Ado-Ekiti between 1 Results: the mean age of the women was 30.43 years (SD 4.524). Thirty-three (16.5%) of the women studied were into hospital-related professions while 6 (3%) were hairdressers. Sixteen (16) of the 200 women tested positive for HBsAg giving a maternal sero-prevalence of 8% while only 1 of the 200 babies tested positive for HBsAg with a neonatal sero-prevalence of 0.5%. The vertical transmission was 6.25%. Conclusion: high endemicity of hepatitis B virus infection in pregnancy was demonstrated in the study. It has, therefore, become imperative to strengthen the structure of the various preventive arms of hepatitis B infection in pregnancy such as advocacy on increased community awareness and handling of risk factors, widespread vaccination campaigns, and routine testing during prenatal care.

Indexed as

Hepatitis BHepatitis B Surface AntigensInfectious Disease Transmission, VerticalPregnancy Complications, InfectiousAdolescentAdultCross-Sectional StudiesFemaleFetal BloodHumansInfant, NewbornNigeriaPregnancyPrevalenceRisk FactorsSeroepidemiologic StudiesHepatitis B Surface Antigensdeliveryhepatitis B antigenemiamaternalNigeriarisk factorsSero-prevalenceumbilical cord

Identifiers

PMID39911365
PMCPMC11795117

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.